Avid Bioservices Inc (CDMO)

[jessme]

I believe we had great results in bavi animal studies with viral also yet the government didn't renew our grant.
We've always had great results in animal studies for various diseases. 1 in 5000 make it from the lab to FDA approval. Yesterday's PR included actual human data and we ended up a penny. How is tha actual human trial doing?
Will we maintain today's spike or give it back?


Peregrine's PS-Targeting Antibody Significantly Improves Anti-Tumor Effect of Sorafenib in Models of Advanced Liver Cancer


As presented today at AACR, tumor growth was 69% less for the group receiving Peregrine's antibody in combination with sorafenib than for the group receiving sorafenib alone (mean tumor weight of 127 mg versus 409 mg, n=10, p < 0.01) after 59 days of treatment in an animal model study.